Edouard Larrey

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area

Giuliana Amaddeo, Raffaele Brustia, Manon Allaire et al. · JHEP Reports · 2020 · 80 citations · Full text

Medicine, Oncology, Cancer Control +13

Baseline <scp>ALBI</scp> score and early variation of serum <scp>AFP</scp> predicts outcomes in patients with <scp>HCC</scp> treated by atezolizumab–bevacizumab

Claudia Campani, Jessica Bamba‐Funck, Bertille Campion et al. · Liver International · 2022 · 47 citations

Medicine, Oncology, Pharmacotherapy +16

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with <scp>HCC</scp>

Edouard Larrey, Bertille Campion, Manon Evain et al. · Liver International · 2022 · 37 citations

Medicine, Oncology, Pharmacotherapy +17

Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma

Manon Allaire, Bertille Campion, Alix Demory et al. · Alimentary Pharmacology & Therapeutics · 2023 · 36 citations

Medicine, Hematology, Internal Medicine +17

Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab

Philippe Sultanik, Claudia Campani, Edouard Larrey et al. · Digestive and Liver Disease · 2024 · 20 citations

Medicine, Oncology, Pharmacotherapy +15